A recent challenge has seen significant participation, with over 2,000 molecule submissions in just three days. The event, known as the Open Discovery Challenge, is hosted by VIDRAFT. Early results show Claude leading, while Chinese open models are also performing well, rivaling OpenAI.

Further details about the challenge and its participants are available. The challenge aims to compare the capabilities of different AI models, including OpenAI, Claude, Gemini, and DeepSeek, in discovering drug candidates.

More information about the Open Discovery Challenge and its outcomes can be found through VIDRAFT, providing insights into the performance of various AI models in this context.